Capnocytophaga bacteremia: Clinical features of patients and antimicrobial, susceptibility of isolates

Journal of the Formosan Medical Association

Volumn 97, Issue 1, 1998, Pages 44-48

  Lin, Rong Dih ^a   Hsueh, Po Ren ^a   Chang, Shan Chwen ^a   Luh, Kwen Tay ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antimicrobial therapy; Capnocytophaga bacteremia; Granulocytopenia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; NETILMICIN; PENICILLIN G; PIPERACILLIN; QUINOLONE DERIVATIVE; TETRACYCLINE; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BRONCHIECTASIS; CAPNOCYTOPHAGA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; GRANULOCYTOPENIA; HUMAN; HYPERTHYROIDISM; MALE; NEOPLASM; NEUTROPENIA; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CAPNOCYTOPHAGA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; TAIWAN;

EID: 0031889551     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Leadbetter ER, Holt SC, Socransky SS: Capnocytophaga: new genus of gram-negative gliding bacteria. I. General characteristics, taxonomic considerations and significance. Arch Microbiol 1979;122:9-16.
2. Newman MG, Sutter VL, Pickett MJ, et al: Detection, identification and comparison of Gapnocytophaga, Bacieroides ochraceui, and DF-1. J Clin Microbiol 1979;10: 557-62.
3. Williams BL, Hollis D, Holdeman LV: Synonomy of strains of Centers for Diseases Control group DF-1 with species of Capnocytophaga. J Clin Microbiol 1979;10: 550-6.
4. Newman MG, Socransky SS, Savitt ED, et al: Studies of the microbiology of periodontosis. J Periodontol 1976,47:373-9.
5. Parenti DM. Snydman DR: Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts. J Infect Dis 1985;151:140-7.
6. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-31.
7. Holmes B, Pickett MJ, Hollis DG: Unusual gram-negative bacteria, including Capnocytophaga, Eikenella, Pasteurella, and Streptobacilli. In: Murray PR, Baron EJ, Pfaller MA, et al, eds. Manual of Clinical Microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:499-508.
8. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. NCCLS Document No M2-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1985.
9. Clark WA, Hollis DG, Weaver RE, et al: Identification of unusual pathogenic gram-negative aerobic and facultatively anaerobic bacteria. Centers for Disease Control, Atlanta, 1984.
10. Campbell JR, Edwards MS. Capnocytophaga species infections in children. Pediatr Infect Dis J 1991;10:944-8.
11. Bilgrami S, Bergstrom SK, Peterson DE, et al: Capnocytophaga bacteremia in a patient with Hodgkin's disease following bone marrow transplantation: case report and review. Clin Infect Dis 1992;14:1045-9.
12. Rummens JL, Gordts B, Van Landuyt HW: In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents. Antimicrob Agents Chemother 1986;30:739-42.
13. Bremmelgaard A, Pers C, Kristiansen JE, et al: Susceptibility testing of Danish isolates of Capnocytophaga and CDC group DF-2 bacteremia. Acta Pathol Microbiol Immunol Scand 1989;97:43-8.
14. Roscoe DL, Zemcov SJV, Thornber D, et al: Antimicrobial susceptibilities and β-lactamase characterization of Capnocytophaga species. Antimicrob Agents Chemother 1992;36:2197-200.
15. Munford RS: Sepsis and septic shock. In: Wilsone JD, Braunwald E, Isselbacher Kf, et al. eds. Harrison's Principles of Internal Medicine. 12th ed. New York: McGraw Hill, 1994:511-5.